Widetrial is supporting an expanded access program (EAP) to bring MN-166 (ibudilast) to ALS patients ineligible for clinical ...

The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...

Ractigen's RAG-21, a treatment for ALS linked to mutations in the FUS gene, has been granted orphan drug designation in the U ...

Although she did everything possible to learn about ALS, columnist Juliet Taylor says the disease often left her feeling ...

A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...

Columnist Kristin Neva learns to self-apply cognitive behavioral therapy techniques, as a do-it-yourself approach has always served her well.

The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.

Enter Keyword. Search for Events by Keyword.